Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches
- DOI
- 10.1016/j.jsps.2023.101775
- Published
- 2023-10
- Container
- Saudi Pharmaceutical Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jsps.2023.101775,
title = {Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches},
author = {Abbas Khan and Ayesha Liaqat and Adan Masood and Syed Shujait Ali and Liaqat Ali and Abdulrahman Alshammari and Abdullah F. Alasmari and Anwar Mohammad and Yasir Waheed and Dong-Qing Wei},
year = {2023},
journal = {Saudi Pharmaceutical Journal},
doi = {10.1016/j.jsps.2023.101775},
url = {https://doi.org/10.1016/j.jsps.2023.101775}
}RIS
TY - JOUR TI - Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches AU - Abbas Khan AU - Ayesha Liaqat AU - Adan Masood AU - Syed Shujait Ali AU - Liaqat Ali AU - Abdulrahman Alshammari AU - Abdullah F. Alasmari AU - Anwar Mohammad AU - Yasir Waheed AU - Dong-Qing Wei PY - 2023 JO - Saudi Pharmaceutical Journal DO - 10.1016/j.jsps.2023.101775 UR - https://doi.org/10.1016/j.jsps.2023.101775 ER -
APA
Khan, A., Liaqat, A., Masood, A., Ali, S. S., Ali, L., Alshammari, A., Alasmari, A. F., Mohammad, A., Waheed, Y., & Wei, D. (2023). Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2023.101775
Source records
- crossref · retrieved 2026-09-26T03:20:41.077Z